ERBB2 and breast carcinoma: The uniqueness of our case report is that T-DXd demonstrated dramatic and rapid response in a metastatic HR positive, HER2 low breast cancer patient with LM complicated by hydrocephalus who had debilitating neurologic symptoms on presentation, and had not yet received any local regional treatment such as surgical intervention or radiation treatment.